HomeInsightsMarket Capitalization

Market Capitalization of Syngene International Ltd

Market Capitalization of Syngene International Ltd

stocks purchased

₹ 0.6 Cr

Volume transacted

stocks purchased

6.4 K

stocks traded

Last Updated time: 14 Oct 15:30 PM

Image

Syngene International Ltd

NSE: SYNGENE

MARKETCAP

35421.24 crore

Last updated: 11 Oct 24

Key Highlights

  • The Market Cap of Syngene International Ltd is ₹ 35421 crore as of 11 Oct 24.
  • The Market Cap of Syngene International Ltd changed from ₹ 11759 crore on March 2019 to ₹ 28209 crore on March 2024 . This represents a CAGR of 15.70% over 6 years. .
  • The Latest Trading Price of Syngene International Ltd is ₹ 889.5 as of 14 Oct 15:30.

Historical Market Cap of Syngene International Ltd

No data available

* All values are in crore

Company Fundamentals for Syngene International Ltd

No data available

Image

Syngene International Ltd

NSE: SYNGENE

PRICE

889.5

9.55 (1.09%)

stock direction

Last updated: 14 Oct 15:30

Market price Over Time

1M

1Y

3Y

5Y

Monitoring Syngene International Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPriceleft
11 Oct 2024879.95
10 Oct 2024880.7
09 Oct 2024886.5
08 Oct 2024877.35
07 Oct 2024868
04 Oct 2024865.95
03 Oct 2024883.05
01 Oct 2024909.6
30 Sep 2024898.65
27 Sep 2024885.15

SWOT Analysis Of Syngene International Ltd

Strength

2

S

Weakness

0

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Syngene International Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Syngene International Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/E Ratio

Key Valuation Metric of Syngene International Ltd

No data available

Historical P/E Ratio of Syngene International Ltd

No data available

* All values are in %

Historical Revenue of Syngene International Ltd

No data available

* All values are in crore

Historical EBITDA of Syngene International Ltd

No data available

* All values are in crore

Historical Net Profit of Syngene International Ltd

No data available

* All values are in crore

Historical Dividend Payout of Syngene International Ltd

No data available

* All values are in %

About Syngene International Ltd

  • Syngene International Limited is an integrated research, development and manufacturing services organization serving global pharmaceutical, biotechnology, nutrition, animal health, consumer goods and specialty chemical sectors.
  • Headquartered in India, the operations are driven by its highly qualified teams comprising ~6000 scientists and its state-of-the-art facilities, spread over 2.2 million sq. ft., across 3 locations in India: Bangalore, Hyderabad and Mangalore.
  • The Company operate into 4 business divisions comprising of Discovery Services, Development Services, Manufacturing Services and the Dedicated Centers. The Company was promoted by Biocon and Kiran Mazumdar Shaw, a promoter of Biocon Limited.
  • The Company's health-related services extend across all major therapeutic areas and modalities.

Syngene International Ltd News Hub

News

Syngene International to convene board meeting

Syngene International will hold a meeting of the Board of Directors of the Company on 23 O...

Read more

05 Oct 202410:06

News

Syngene International to convene board meeting

Syngene International will hold a meeting of the Board of Directors of the Company on 24 J...

Read more

29 Jun 202410:02

News

Syngene International schedules AGM

Syngene International announced that the 31th Annual General Meeting (AGM) of the company ...

Read more

25 Apr 202410:40

News

Syngene Intl records PAT of Rs 189 crore in Q4; EBITDA margin at 36%

Material costs declined by 30.9% YoY to Rs 202.8 crore in the fourth quarter due to revers...

Read more

25 Apr 202412:22

News

Board of Syngene International recommends final dividend

Syngene International announced that the Board of Directors of the Company at its meeting ...

Read more

24 Apr 202420:36

News

Syngene International to hold board meeting

Syngene International will hold a meeting of the Board of Directors of the Company on 24 A...

Read more

01 Apr 202417:38

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

FAQs for Market Cap of Syngene International Ltd

What is the market cap of Syngene International Ltd?

As of October 14, 2024, Syngene International Ltd has a market capitalization of ₹35421.24, however, this figure is subject to change due to fluctuations in its stock price and market conditions.

What factors influence Syngene International Ltd's market capitalization?

Syngene International Ltd's market capitalization is influenced by factors such as its financial performance, and the company’s ability to innovate and adapt to market trends. Moreover, macroeconomic factors like economic conditions, currency fluctuations, and global automotive industry trends also affect its market capitalization.

Can market capitalization be used to predict future stock performance of Syngene International Ltd?

Market capitalization alone is not a reliable predictor of future stock performance, as it reflects the current value of a company's equity rather than its future potential. To forecast %s's future stock performance, investors should consider additional factors such as financial health, growth prospects, industry trends, and broader economic conditions.

How often does Syngene International Ltd's market capitalization change?

Syngene International Ltd's market capitalization can change frequently, within a single trading day, due to fluctuations in stock price. These changes are influenced by market conditions, investor sentiment, company performance, and broader economic factors. Therefore, tracking its market capitalization requires continuous monitoring of stock price movements and related financial news.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*